Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Trump may loosen drug patent protections to push trade pact

The pharmaceutical industry could be in for a loss as the Trump administration considers easing patent protection rules in order to garner support from Democrats for a new trade pact between the U.S., Mexico and Canada­––USMCA, The Wall Street Journal reported.

Thumbnail

HHS to make HIV prevention medication free for uninsured

HHS has announced a new initiative to make a medication taken to prevent HIV, pre-exposure prophylaxis, or PrEP, available for free to those without prescription drug insurance coverage.

Thumbnail

CVS enters new deal with Centene

CVS Health is acquiring Centene’s Illinois health plan subsidiary, IlliniCare Health Plan, the companies announced Dec. 2. Financial terms of the transaction were not disclosed.

 

Thumbnail

RSNA 2019: Dr. Vijay Rao on why hospital radiology departments must grow to compete

Hospital radiology departments hoping to survive and thrive in healthcare’s volume-to-value era must get creative—and even somewhat aggressive—about growing their outpatient business.

Thumbnail

Global medical costs will rise again in 2020

Medical care costs are set to rise again in 2020, with a projected increased of 6.8%, according to the 2020 Global Medical Trends Survey Report from Willis Towers Watson.

 

Thumbnail

Reconciliation limitations led CMS to overpay hospitals $500M

Hospitals were overpaid by roughly $502 million from 2011 to 2014, according to a report from the Office of Inspector General (OIG), which blamed the overpayment on CMS limitations on the reconciliation period.

Thumbnail

Trump’s drug importation plan faces news challenges

President Trump’s plan to allow the importation of certain drugs from Canada is facing new challenges from the Canadian government, according to The Hill.

 

Thumbnail

Feds open criminal probe into opioid makers

Pharmaceutical companies are under fire again for their role in the national opioid abuse epidemic, and this time, it could be criminal. Federal prosecutors have opened a criminal probe to determine if pharmaceutical companies intentionally allowed the flow of opioid drugs, The Wall Street Journal reported.